COVANCE

• 70100 - Activities of head offices

Labcorp Drug Development (formerly Covance) is a global contract research organization (CRO) that provides drug development services with the goal of advancing health. We have supported the development of the top 50 pharmaceutical drugs on the market. As a full-service CRO, we are dedicated to providing nonclinical, preclinical, clinical, commercialization and regulatory consulting, research and testing services to pharmaceutical and biotechnology companies. Our mission is to improve health and improve lives... We believe in harnessing science for human good. And so we work day and night, around the world, to deliver answers for all your health questions-whether you're a provider, drug developer, hospital, medical researcher or patient. That means everything from advancing diagnostic testing, to helping launch new drugs, to offering new perspectives through data, all drawing from a deep well of scientific expertise... Whether we're working in the lab, on the road, in the air, in a..

Also known as: FORTREA UK HOLDINGS LIMITED, Labcorp Drug Development

Previous names: COVANCE LIMITED, LABCORP DEVELOPMENT LIMITED

Registration numbers: 02660917 (CH)

Primary location: Burlington United States